Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renal Artery Stent Combined With Medical Therapy in RAS
NCT02594410Phase 4Completed
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Sep 2011
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lercanidipine in hypertension (HTN), sponsored by Lee's Pharmaceutical Holdings Limited. Primary endpoints: Glomerular filtration rate at 12 months and Blood pressure at 12 months. Started Sep 2011; status: completed.
02
Drugs
lercanidipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02594410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02594410.